​Longevity Biotech : Venture Capital Investing and Future of Medicine

​Join our biohacking community for a talk exploring longevity biotech, venture capital investing, and the future of medicine with Sebastian A. Brunemeier.

​Sebastian is a biotech investor and company builder focused on longevity and regenerative medicine. He is Co-Founder & General Partner of Healthspan Capital and Venture Partner at Long Game Ventures. Previously, he co-founded Cambrian Biopharma, which raised $200M, founded Samsara Therapeutics, and served as Principal at Apollo Health Ventures.

​

​

​His scientific background includes biochemistry research at Oxford as a Clarendon Scholar, telomere biology as a Fulbright Fellow, and research at the Buck Institute. He brings both a scientific and investment perspective on turning longevity discoveries into new medicines.

​Over the talk, we’ll explore the science behind extending healthy lifespan, how investors evaluate longevity startups, and what it takes to bring promising discoveries from the lab to patients.

​Expect an informal evening of conversation, questions, and new connections with fellow biohackers, founders, and curious minds.

Presentation by Sebastian Brunemeier to the National University of Singapore School of Medicine (6:30 min timestamp)